Tidal Investments LLC decreased its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 29.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,177 shares of the medical device company's stock after selling 4,192 shares during the period. Tidal Investments LLC's holdings in Cooper Companies were worth $936,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its holdings in Cooper Companies by 517.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after purchasing an additional 2,957,421 shares in the last quarter. Norges Bank purchased a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $217,906,000. FMR LLC grew its holdings in Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after acquiring an additional 1,095,805 shares during the period. Raymond James Financial Inc. purchased a new position in Cooper Companies in the fourth quarter worth $64,826,000. Finally, Victory Capital Management Inc. boosted its position in shares of Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after purchasing an additional 574,899 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
COO has been the subject of a number of research analyst reports. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Thursday, May 22nd. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Robert W. Baird reduced their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Citigroup lowered their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a report on Wednesday, May 21st. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $110.25.
Check Out Our Latest Stock Analysis on Cooper Companies
Cooper Companies Price Performance
Cooper Companies stock traded up $0.15 during mid-day trading on Thursday, hitting $80.27. 2,244,134 shares of the company were exchanged, compared to its average volume of 1,504,924. The Cooper Companies, Inc. has a 12-month low of $69.81 and a 12-month high of $112.38. The company has a market capitalization of $16.05 billion, a P/E ratio of 41.17, a PEG ratio of 2.25 and a beta of 1.08. The business's 50 day simple moving average is $80.20 and its two-hundred day simple moving average is $88.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.
Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
Cooper Companies Company Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
